India News | COVID-19: Nasal Vaccine Could Be a Game-changer if It Provides Mucosal Immunity, Says AIIMS Epidemiologist
Get latest articles and stories on India at LatestLY. As Hyderabad-based drug maker Bharat Biotech has got regulatory approval to conduct Phase-3 clinical trials of its intranasal COVID-19 vaccine as a booster dose, senior epidemiologist in All India Institute of Medical Sciences (AIIMS) in Delhi, Dr Sanjay Rai, on Sunday said the vaccine could be a game-changer in the fight against the pandemic if it provides mucosal immunity. India News | COVID-19: Nasal Vaccine Could Be a Game-changer if It Provides Mucosal Immunity, Says AIIMS Epidemiologist.